- PR Newswire•yesterdayJohnson & Weaver, LLP Announces Investigations of Clovis Oncology, Inc., USANA Health Sciences, Inc., Anthera Pharmaceuticals, Inc., and PixarBio Corporation
Johnson & Weaver, LLP is investigating potential violations of federal and state securities laws by Clovis Oncology, Inc. (CLVS) and certain of its officers. On November 19, 2015, a class action lawsuit was filed against Clovis over alleged securities laws violations.
- Accesswire•2 days agoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against USANA Health Sciences, Inc., and Encourages Investors with Losses to Contact the Firm
IRVINE, CA / ACCESSWIRE / February 17, 2017 / Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against USANA Health Sciences, Inc. ("USANA" or the "Company") ...
- Business Wire•3 days agoRobbins Arroyo LLP: USANA Health Sciences, Inc. (USNA) Misled Shareholders According to a Recently Filed Class Action
Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against USANA Health Sciences, Inc. in the U.S. District Court for the District of Utah.
USNA : Summary for USANA Health Sciences, Inc. Com - Yahoo Finance
USANA Health Sciences, Inc. (USNA)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||57.70 - 59.45|
|52 Week Range||54.25 - 150.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||14.57|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|